Project Grant R01AI189215
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $971,109 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Merced, effective June 10, 2025, with a completion date of May 31, 2028. This research initiative investigates the DNA binding dynamics and oligomerization mechanisms of pattern recognition receptors in the PYHIN (Pyrin and HIN-domain-containing protein) family,...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $435,875 to the University of California, Merced under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 18, 2025, for a project period extending through June 30, 2027. This Project Grant supports basic immunological research investigating the role of NFKBID (nuclear factor kappa-light-chain-enhancer of activated B cells inhibitor delta) in humoral immunity to...
- Federal Grant Award Summary The University of California, San Diego received a $3.19 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 16, 2025, with a completion date of June 30, 2029. This award supports biomedical research investigating the roles and regulation of tissue-resident CD8 T cells during persistent viral infections, specifically utilizing a mouse...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $438,500 to the University of California, San Diego for a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 8, 2025, with a completion date of June 30, 2027. The research project focuses on characterizing sequence-specific determinants and impacts of NS2 (non-structural protein 2) interactions with the influenza A virus (IAV) polymerase...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $736,920 to the University of California, Los Angeles under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 22, 2025, for a project period extending through June 30, 2030. This Project Grant funds fundamental research on trypanosome flagellum structure, assembly, and mechanism, with the objective of advancing scientific understanding of Trypanosoma brucei...
- Federal Grant Award Summary The University of California, San Diego received a $3.02 million Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 8, 2025, with a completion date of June 30, 2029. This award funds a four-year basic science research project investigating the regulatory T (Treg) cell-derived interleukin-27 (IL-27) axis and its role in immune regulation, particularly in...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $744,328 Project Grant to the University of California, Davis on February 13, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, with an ultimate completion date of January 31, 2031, supports biomedical research investigating the pathogenic mechanisms of Entamoeba histolytica, the parasitic amoeba responsible for amoebiasis in humans. The research...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $451,000 to the University of California, San Francisco under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 15, 2025, for a project period extending through July 31, 2027. This Project Grant funds the development of high-resolution phage immunoprecipitation sequencing (PhIP-Seq) arrays to comprehensively evaluate antibody responses to Plasmodium...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded University of California, Davis $431,004 on July 18, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support biomedical research investigating the mechanisms of trogocytosis—a cell-nibbling process—between Entamoeba histolytica amoebae and human cells. The project, which extends through June 30, 2027, will advance fundamental understanding of how this...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases awarded a $2.83 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Irvine on July 14, 2025, with a completion date of June 30, 2029. This research grant supports a four-year investigation into the metabolic regulation of virus-specific T cell immunity by SAPS3 (Serine/Threonine-Protein Phosphatase 6 Regulatory Subunit 3). The...
The National Institute of Allergy and Infectious Diseases awarded a $647,181 Project Grant to the University of California, Merced for research titled "Elucidating Factors Involved in Inflammasome Regulation." The award, effective February 1, 2026, through January 31, 2031, supports fundamental research investigating the regulatory mechanisms controlling inflammasome assembly and activity in innate immune cells. The project focuses on understanding how inflammasomes—large multiprotein complexes that trigger inflammatory responses to pathogenic threats—are formed and regulated, with particular emphasis on the adaptor protein ASC and its interaction with cytosolic pattern recognition receptors. This research is designed to elucidate atomic-level structural and biophysical mechanisms underlying inflammasome formation, providing scientific knowledge essential for developing targeted anti-inflammatory therapies for autoimmune disorders, autoinflammatory diseases, atherosclerosis, and cancer. UC Merced will conduct this research under the National Institute of Allergy and Infectious Diseases' Allergy and Infectious Diseases Research program (CFDA 93.855), which supports biomedical research advancing scientific understanding of infectious, immunologic, and allergic diseases. The research program emphasizes competitive merit-based selection and will utilize UC Merced's established research capabilities in immunology and structural biology to advance knowledge of disease mechanisms and inform therapeutic development strategies.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $647.2k | 2/1/26 |